Vanda Pharmaceuticals (VNDA) Tax Rate Growth (3y) (2020 - 2026)
Vanda Pharmaceuticals (VNDA) Tax Rate Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Vanda Pharmaceuticals | 310.98 Mn | 108.67 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,181.00 |
| Dec 31, 2025 | -30,015.00 |
| Sep 30, 2025 | -1,986.00 |
| Jun 30, 2025 | -959.00 |
| Mar 31, 2025 | 653.00 |
| Dec 31, 2024 | 716.00 |
| Sep 30, 2024 | -1,357.00 |
| Jun 30, 2024 | -532.00 |
| Mar 31, 2024 | -594.00 |
| Dec 31, 2023 | -6,883.00 |
| Sep 30, 2023 | 18,496.00 |
| Jun 30, 2023 | 2,080.00 |
| Mar 31, 2023 | -1,923.00 |
| Dec 31, 2022 | 152.00 |
| Sep 30, 2022 | 75,795.00 |
| Jun 30, 2022 | 3,151.00 |
| Mar 31, 2022 | 1,620.00 |
| Dec 31, 2021 | 1,839.00 |
| Sep 30, 2021 | 2,671.00 |
| Jun 30, 2021 | 2,150.00 |